AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
BIPHASIC KINETICS OF PERIPHERAL-BLOOD T-CELLS AFTER TRIPLE COMBINATION THERAPY IN HIV-1 INFECTION - A COMPOSITE OF REDISTRIBUTION AND PROLIFERATION
Authors: PARKER NG NOTERMANS DW DEBOER RJ ROOS MTL DEWOLF F HILL A LEONARD JM DANNER SA MIEDEMA F SCHELLEKENS PTA
Citation: Ng. Parker et al., BIPHASIC KINETICS OF PERIPHERAL-BLOOD T-CELLS AFTER TRIPLE COMBINATION THERAPY IN HIV-1 INFECTION - A COMPOSITE OF REDISTRIBUTION AND PROLIFERATION, Nature medicine, 4(2), 1998, pp. 208-214
CONDENSING ENZYMES FROM CUPHEA-WRIGHTII ASSOCIATED WITH MEDIUM-CHAIN FATTY-ACID BIOSYNTHESIS
Authors: SLABAUGH MB LEONARD JM KNAPP SJ
Citation: Mb. Slabaugh et al., CONDENSING ENZYMES FROM CUPHEA-WRIGHTII ASSOCIATED WITH MEDIUM-CHAIN FATTY-ACID BIOSYNTHESIS, Plant journal, 13(5), 1998, pp. 611-620
A CUPHEA BETA-KETOACYL-ACP SYNTHASE SHIFTS THE SYNTHESIS OF FATTY-ACIDS TOWARDS SHORTER CHAINS IN ARABIDOPSIS SEEDS EXPRESSING CUPHEA FATB THIOESTERASES
Authors: LEONARD JM KNAPP SJ SLABAUGH MB
Citation: Jm. Leonard et al., A CUPHEA BETA-KETOACYL-ACP SYNTHASE SHIFTS THE SYNTHESIS OF FATTY-ACIDS TOWARDS SHORTER CHAINS IN ARABIDOPSIS SEEDS EXPRESSING CUPHEA FATB THIOESTERASES, Plant journal, 13(5), 1998, pp. 621-628
EFFECT OF RITONAVIR ON THE PHARMACOKINETICS OF ETHINYL ESTRADIOL IN HEALTHY FEMALE VOLUNTEERS
Authors: OUELLET D HSU A QIAN J LOCKE CS EASON CJ CAVANAUGH JH LEONARD JM GRANNEMAN GR
Citation: D. Ouellet et al., EFFECT OF RITONAVIR ON THE PHARMACOKINETICS OF ETHINYL ESTRADIOL IN HEALTHY FEMALE VOLUNTEERS, British journal of clinical pharmacology, 46(2), 1998, pp. 111-116
THE DURATION OF VIRAL SUPPRESSION DURING PROTEASE INHIBITOR THERAPY FOR HIV-1 INFECTION IS PREDICTED BY PLASMA HIV-1 RNA AT THE NADIR
Authors: KEMPF DJ RODE RA XU Y SUN E HEATHCHIOZZI ME VALDES J JAPOUR AJ DANNER S BOUCHER C MOLLA A LEONARD JM
Citation: Dj. Kempf et al., THE DURATION OF VIRAL SUPPRESSION DURING PROTEASE INHIBITOR THERAPY FOR HIV-1 INFECTION IS PREDICTED BY PLASMA HIV-1 RNA AT THE NADIR, AIDS, 12(5), 1998, pp. 9-14
DECREASE OF HIV-1 RNA LEVELS IN LYMPHOID-TISSUE AND PERIPHERAL-BLOOD DURING TREATMENT WITH RITONAVIR, LAMIVUDINE AND ZIDOVUDINE
Authors: NOTERMANS DW JURRIAANS S DEWOLF F FOUDRAINE NA DEJONG JJ CAVERT W SCHUWIRTH CM KAUFFMANN RH MEENHORST PL MCDADE H GOODWIN C LEONARD JM GOUDSMIT J DANNER SA
Citation: Dw. Notermans et al., DECREASE OF HIV-1 RNA LEVELS IN LYMPHOID-TISSUE AND PERIPHERAL-BLOOD DURING TREATMENT WITH RITONAVIR, LAMIVUDINE AND ZIDOVUDINE, AIDS, 12(2), 1998, pp. 167-173
PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND INDINAVIR IN HEALTHY-VOLUNTEERS
Authors: HSU A GRANNEMAN GR CAO GL CAROTHERS L JAPOUR A ELSHOURBAGY T DENNIS S BERG J ERDMAN K LEONARD JM SUN EG
Citation: A. Hsu et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND INDINAVIR IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2784-2791
HUMAN SERUM ATTENUATES THE ACTIVITY OF PROTEASE INHIBITORS TOWARD WILD-TYPE AND MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: MOLLA A VASAVANONDA S KUMAR G SHAM HL JOHNSON M GRABOWSKI B DENISSEN JF KOHLBRENNER W PLATTNER JJ LEONARD JM NORBECK DW KEMPF DJ
Citation: A. Molla et al., HUMAN SERUM ATTENUATES THE ACTIVITY OF PROTEASE INHIBITORS TOWARD WILD-TYPE AND MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS, Virology (New York, N.Y. Print), 250(2), 1998, pp. 255-262
IN-VITRO SELECTION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED RESISTANCE TO ABT-378, A NOVEL PROTEASE INHIBITOR
Authors: CARRILLO A STEWART KD SHAM HL NORBECK DW KOHLBRENNER WE LEONARD JM KEMPF DJ MOLLA A
Citation: A. Carrillo et al., IN-VITRO SELECTION AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED RESISTANCE TO ABT-378, A NOVEL PROTEASE INHIBITOR, Journal of virology, 72(9), 1998, pp. 7532-7541
GENOTYPIC CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED WITH LOSS OF SUPPRESSION OF PLASMA VIRAL-RNA LEVELS IN SUBJECTS TREATEDWITH RITONAVIR (NORVIR) MONOTHERAPY
Authors: EASTMAN PS MITTLER J KELSO R GEE C BOYER E KOLBERG J URDEA M LEONARD JM NORBECK DW MO HM MARKOWITZ M
Citation: Ps. Eastman et al., GENOTYPIC CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED WITH LOSS OF SUPPRESSION OF PLASMA VIRAL-RNA LEVELS IN SUBJECTS TREATEDWITH RITONAVIR (NORVIR) MONOTHERAPY, Journal of virology, 72(6), 1998, pp. 5154-5164
IMMUNOLOGICAL RESPONSES ASSOCIATED WITH 12 WEEKS OF COMBINATION ANTIRETROVIRAL THERAPY CONSISTING OF ZIDOVUDINE, LAMIVUDINE, AND RITONAVIR - RESULTS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-315
Authors: LEDERMAN MM CONNICK E LANDAY A KURITZKES DR SPRITZLER J STCLAIR M KOTZIN BL FOX L CHIOZZI H LEONARD JM ROUSSEAU F WADE M ROE JD MARTINEZ A KESSLER H
Citation: Mm. Lederman et al., IMMUNOLOGICAL RESPONSES ASSOCIATED WITH 12 WEEKS OF COMBINATION ANTIRETROVIRAL THERAPY CONSISTING OF ZIDOVUDINE, LAMIVUDINE, AND RITONAVIR - RESULTS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-315, The Journal of infectious diseases, 178(1), 1998, pp. 70-79
IMPROVEMENT IN CELL-MEDIATED IMMUNE FUNCTION DURING POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY WITH RITONAVIR PLUS SAQUINAVIR
Authors: ANGEL JB KUMAR A PARATO K FILION LG DIAZMITOMA F DAFTARIAN P PHAM B SUN E LEONARD JM CAMERON DW
Citation: Jb. Angel et al., IMPROVEMENT IN CELL-MEDIATED IMMUNE FUNCTION DURING POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY WITH RITONAVIR PLUS SAQUINAVIR, The Journal of infectious diseases, 177(4), 1998, pp. 898-904
PHILO STUDIES - FRENCH - NIKIPROWETZKY,V
Authors: LEONARD JM
Citation: Jm. Leonard, PHILO STUDIES - FRENCH - NIKIPROWETZKY,V, Etudes theologiques et religieuses, 73(2), 1998, pp. 270-271
THE JEWISH APOCALYPTIC HERITAGE IN EARLY CHRISTIANITY - VANDERKAM,JC,ADLER,W
Authors: LEONARD JM
Citation: Jm. Leonard, THE JEWISH APOCALYPTIC HERITAGE IN EARLY CHRISTIANITY - VANDERKAM,JC,ADLER,W, Etudes theologiques et religieuses, 73(2), 1998, pp. 270-270
THE SAGES OF ISRAEL - CONCEPTS AND BELIEF S OF THE MASTERS OF THE TALMUD - FRENCH - URBACH,EE
Authors: LEONARD JM
Citation: Jm. Leonard, THE SAGES OF ISRAEL - CONCEPTS AND BELIEF S OF THE MASTERS OF THE TALMUD - FRENCH - URBACH,EE, Etudes theologiques et religieuses, 73(2), 1998, pp. 271-272
PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN
Authors: OUELLET D HSU A GRANNEMAN GR CARLSON G CAVANAUGH J GUENTHER H LEONARD JM
Citation: D. Ouellet et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 355-362
PHARMACOKINETIC INTERACTIONS BETWEEN 2 HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS, RITONAVIR AND SAQUINAVIR
Authors: HSU A GRANNEMAN GR CAO GL CAROTHERS L ELSHOURBAGY T BAROLDI P ERDMAN K BROWN F SUN E LEONARD JM
Citation: A. Hsu et al., PHARMACOKINETIC INTERACTIONS BETWEEN 2 HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS, RITONAVIR AND SAQUINAVIR, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 453-464
CUPHEA WRIGHTII THIOESTERASES HAVE UNEXPECTED BROAD SPECIFICITIES ON SATURATED FATTY-ACIDS
Authors: LEONARD JM SLABAUGH MB KNAPP SJ
Citation: Jm. Leonard et al., CUPHEA WRIGHTII THIOESTERASES HAVE UNEXPECTED BROAD SPECIFICITIES ON SATURATED FATTY-ACIDS, Plant molecular biology, 34(4), 1997, pp. 669-679
MULTIPLE-DOSE PHARMACOKINETICS OF RITONAVIR IN HUMAN IMMUNODEFICIENCYVIRUS-INFECTED SUBJECTS
Authors: HSU A GRANNEMAN GR WITT G LOCKE C DENISSEN J MOLLA A VALDES J SMITH J ERDMAN K LYONS N NIU P DECOURT JP FOURTILLAN JB GIRAULT J LEONARD JM
Citation: A. Hsu et al., MULTIPLE-DOSE PHARMACOKINETICS OF RITONAVIR IN HUMAN IMMUNODEFICIENCYVIRUS-INFECTED SUBJECTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 898-905
PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR
Authors: KEMPF DJ MARSH KC KUMAR G RODRIGUES AD DENISSEN JF MCDONALD E KUKULKA MJ HSU A GRANNEMAN GR BAROLDI PA SUN E PIZZUTI D PLATTNER JJ NORBECK DW LEONARD JM
Citation: Dj. Kempf et al., PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 654-660
RITONAVIR AND RENAL-FAILURE - REPLY
Authors: LEONARD JM HEATHCHIOZZI M
Citation: Jm. Leonard et M. Heathchiozzi, RITONAVIR AND RENAL-FAILURE - REPLY, The New England journal of medicine, 336(2), 1997, pp. 138-138
CHRISTIANITY AND AFRICAN CULTURE - CONSER VATIVE GERMAN PROTESTANT MISSIONARIES IN TANZANIA, 1900-1940 - FIEDLER,K
Authors: LEONARD JM
Citation: Jm. Leonard, CHRISTIANITY AND AFRICAN CULTURE - CONSER VATIVE GERMAN PROTESTANT MISSIONARIES IN TANZANIA, 1900-1940 - FIEDLER,K, Etudes theologiques et religieuses, 72(3), 1997, pp. 488-489
THE ORIGINS OF THE NEW CHURCHES MOVEMENT IN SOUTHERN ETHIOPIA, 1927-1944 - FARGHER,BL
Authors: LEONARD JM
Citation: Jm. Leonard, THE ORIGINS OF THE NEW CHURCHES MOVEMENT IN SOUTHERN ETHIOPIA, 1927-1944 - FARGHER,BL, Etudes theologiques et religieuses, 72(3), 1997, pp. 489-490
ORDERED ACCUMULATION OF MUTATIONS IN HIV PROTEASE CONFERS RESISTANCE TO RITONAVIR
Authors: MOLLA A KORNEYEVA M GAO Q VASAVANONDA S SCHIPPER PJ MO HM MARKOWITZ M CHERNYAVSKIY T NIU P LYONS N HSU A GRANNEMAN GR HO DD BOUCHER CAB LEONARD JM NORBECK DW KEMPF DJ
Citation: A. Molla et al., ORDERED ACCUMULATION OF MUTATIONS IN HIV PROTEASE CONFERS RESISTANCE TO RITONAVIR, Nature medicine, 2(7), 1996, pp. 760-766
HIV-1 DYNAMICS IN-VIVO - VIRION CLEARANCE RATE, INFECTED CELL LIFE-SPAN, AND VIRAL GENERATION TIME
Authors: PERELSON AS NEUMANN AU MARKOWITZ M LEONARD JM HO DD
Citation: As. Perelson et al., HIV-1 DYNAMICS IN-VIVO - VIRION CLEARANCE RATE, INFECTED CELL LIFE-SPAN, AND VIRAL GENERATION TIME, Science, 271(5255), 1996, pp. 1582-1586
Risultati: 1-25 | 26-50